Home Awards and Honors Media Placements Bridging the Cultural Gap Links Contact

News Archive

 

FSD Pharma ‘Hunkering Down’ on Grow Facility and ‘Doubling Down’ on Biosciences Effort

December 4th, 2019

Dr Raza Bokhari, FSD Pharma CEO, tells Christine Corrado of Proactive Investors in Q1 2020 they will begin clinical trials and in human safety and tolerability studies for lead asset, micro-PEA.

Click here to watch the video.

Email to a friend


FSD Pharma advancing its Phase 1 study in Australia

February 10th, 2020

Dr Raza Bokhari at BIO CEO & Investor Conference NYC, says Nucleus Network to conduct Phase 1 in human safety & tolerability study of FSD Pharma's lead candidate PP101 ultra micro PEA in Australia.

Click here to watch the video

FSD Pharma’s “Huge” Plans on Milestone IPO Day

January 23rd, 2020

FSD Pharma CEO, Dr. Raza Bokhari, with Olivia Voznenko on Modern Wall Street, discusses how the company looks to tackle the opioid epidemic by producing opioid sparing medications which can treat chronic pain.

Click here to watch the video.

FSD Pharma Inc. Rings the Opening Bell | NASDAQ

January 22nd, 2020

Dr Raza Bokhari, FSD Pharma CEO, rings the Opening Bell at the NASDAQ Stock exchange.

Click here to watch the video.

View Archive
Home | Awards and Honors | Media Placements | Bridging the Cultural Gap | Links | Contact © 2007 Dr. Raza Bokhari · All rights reserved.